The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: A multicenter, retrospective korean study

Annals of Surgical Oncology

Volumn 16, Issue 10, 2009, Pages 2882-2887

  Lee, Kwang Beom ^a   Ki, Kyung Do ^b   Lee, Jong Min ^b   Lee, Jae Kwan ^c   Kim, Jae Weon ^d   Cho, Chi Heum ^e   Kim, Seok Mo ^f   Park, Sang Yoon ^g   Jeong, Dae Hoon ^h   Kim, Ki Tae ^h  

^a Gachon University College of Medicine   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Seoul National University   (South Korea)

^e Dongsan Medical Center   (South Korea)

^f Chonnam National University   (South Korea)

^g National Cancer Center   (South Korea)

^h Inje University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SIZE; CANCER SURGERY; DISEASE SEVERITY; ENDOMETRIOID UTERINE CANCER; FEMALE; HUMAN; KOREA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; METASTASIS; MYOMETRIAL METASTASIS; PARAAORTIC LYMPHADENECTOMY; PELVIS LYMPHADENECTOMY; RETROSPECTIVE STUDY; RISK ASSESSMENT; UTERUS CANCER; CANCER STAGING; CLINICAL TRIAL; ENDOMETRIUM TUMOR; FOLLOW UP; MALE; MIDDLE AGED; MULTICENTER STUDY; MYOMETRIUM; PATHOLOGY; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KOREA; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MYOMETRIUM; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 73349127174     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0535-0     Document Type: Article

References (30)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide inci-dence of 25 major cancers in 1990. Int J Cancer. 1999; 80:827-41.
2. Annual Report of Gynecologic Cancer Registry Program in Korea for 2004 (Jan. 1st, 2004-Dec. 31st, 2004). Korean J Obstet Gynecol. 2007;50:28-78.
3. Kitchener H. Management of endometrial cancer. Eur J Surg Oncol. 2006;32:838-43
4. American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endo-metrial cancer. Obstet Gynecol. 2005;106:413-25.
5. Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC Current issues in the management of endometrial cancer. Mayo Clin Proc. 2008;83:97-112
6. Announcements. FIGO stages-1988 Revision. Gynecol Oncol. 1989;35:125-7.
7. Chan JK, Kapp DS. Role of complete lymphadenectomy in endometrioid uterine cancer. Lancet Oncol. 2007;8:831-41.
8. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Postoperative radiation therapy in endometrial carcinoma. Lancet. 2000;355:1404-11.
9. Chee JJ, Ho TH, Tay EH, Low JJ, Yam KL. Endometrioid ade-nocarcinoma of the uterus: surgico-pathological correlations and role of pelvic lymphadenectomy. Ann Acad Med Singapore. 2003; 32:670-5.
10. Podratz KC, Mariani A, Webb MJ. Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol Oncol. 1998;70:163-4.
11. Solhjem MC, Petersen IA, Haddock MG Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endo-metrial cancer. Int J Radiat Oncol Biol Phys. 2005;62:1379-84.
12. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F III, Conner W. Adenocarcinoma of the endome-trium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 1995;56:29-33.
13. Mariani A, Webb MJ, Galli L, Podratz KC Potential therapeutic role of para-aortic lymphadenectomy in node-positive endome-trial cancer. Gynecol Oncol. 2000;76:348-56.
14. Cragun JM, Havrilesky LJ, Calingaert B, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005;23:3668-75.
15. Selman TJ, Mann CH, Zamora J, Khan KS. A systematic review of tests for lymph node status in primary endometrial cancer. BMC Womens Health. 2008;8:8.
16. Kitchener H, Redman CW, Swart AM, Amos CL, on behalf of ASTEC Study Group. A study in the treatment of endometrial cancer. A randomised trial of lymphadenectomy in the treatment ofendometrial cancer. Gynecol Oncol. 2006;101:S21-2.
17. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE. Relationship between surgical-path-ological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991;40:55-65.
18. Carey MS, O'Connell GJ, Johanson CR, et al. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adeno-carcinoma of the endometrium. Gynecol Oncol. 1995;57:138-44.
19. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000;182: 1506-19.
20. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns ofendometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60:2035-41.
21. Schink JC, Rademaker AW, Miller DS, Lurain JR. Tumor size in endometrial cancer. Cancer. 1991;67:2791-4.
22. Horowitz NS, Dehdashti F, Herzog TJ, et al. Prospective evalu-ation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol. 2004;95:546-51.
23. Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB, Hricak H. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology. 1999;212:711-8.
24. Kucera E, Kainz C, Reinthaller A, Sliutz G, Leodolter S, Kucera H, Breitenecker G Accuracy of intraoperative frozen-section diagnosis in stage I endometrial adenocarcinoma. Gynecol Obstet Invest. 2000;49:62-6.
25. Lee KB, Lee JM, Park CY, Lee KB, Cho HY, Ha SY. Lymph node metastasis and lymph vascular space invasion in microinvasive squamous cell carcinoma of the uterine cervix. Int J Gynecol Cancer. 2006;16:1184-7.
26. Gynecologic Oncology Group. Surgical procedures manual, July 2005. https://gogmember.gog.org/manuals/pdf/surgman.pdf.
27. Panici PB, Scambia G, Baiocchi G, Matonti G, Capelli A, Mancuso S. Anatomical study of para-aortic and pelvic lymph nodes in gynecologic malignancies. Obstet Gynecol. 1992;79:498-502.
28. Mariani A, Webb MJ, Keeney GL, Podratz KC Routes of lym-phatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol Oncol. 2001;81:100-4.
29. Mariani A, Keeney GL, Aletti G, Webb MJ, Haddock MG, Po-dratz KC Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol. 2004;92:833-8.
30. McMeekin DS, Lashbrook D, Gold M, Johnson G, Walker JL, Mannel R. Analysis of FIGO stage IIIc endometrial cancer patients. Gynecol Oncol. 2001;81:273-8.